LV12240B - ESSENTIALS OF SURFACE METALS 8.9-DEHYDRESTRONES - Google Patents

ESSENTIALS OF SURFACE METALS 8.9-DEHYDRESTRONES Download PDF

Info

Publication number
LV12240B
LV12240B LVP-99-05A LV990005A LV12240B LV 12240 B LV12240 B LV 12240B LV 990005 A LV990005 A LV 990005A LV 12240 B LV12240 B LV 12240B
Authority
LV
Latvia
Prior art keywords
sulfate
alkali metal
dehydro
salt
estrone
Prior art date
Application number
LVP-99-05A
Other languages
English (en)
Latvian (lv)
Other versions
LV12240A (lv
Inventor
Panolil Chirukandoth Raveendranath
John Anthony Wichtowski
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of LV12240A publication Critical patent/LV12240A/xx
Publication of LV12240B publication Critical patent/LV12240B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LVP-99-05A 1992-02-26 1999-01-13 ESSENTIALS OF SURFACE METALS 8.9-DEHYDRESTRONES LV12240B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/841,694 US5210081A (en) 1992-02-26 1992-02-26 Alkali metal 8,9-dehydroestrone sulfate esters

Publications (2)

Publication Number Publication Date
LV12240A LV12240A (lv) 1999-03-20
LV12240B true LV12240B (en) 1999-06-20

Family

ID=25285489

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-99-05A LV12240B (en) 1992-02-26 1999-01-13 ESSENTIALS OF SURFACE METALS 8.9-DEHYDRESTRONES

Country Status (22)

Country Link
US (3) US5210081A (de)
EP (2) EP0864583B1 (de)
JP (1) JP3715645B2 (de)
KR (1) KR100256861B1 (de)
AR (2) AR042262A2 (de)
AT (2) ATE342272T1 (de)
AU (2) AU677181B2 (de)
CA (1) CA2089707A1 (de)
DE (2) DE69334073T2 (de)
DK (2) DK0864583T3 (de)
ES (2) ES2125975T3 (de)
FI (1) FI115915B (de)
GR (1) GR3029620T3 (de)
HK (2) HK1011369A1 (de)
HU (2) HUT67553A (de)
LV (1) LV12240B (de)
MX (1) MX9300969A (de)
PT (1) PT864583E (de)
SG (1) SG49715A1 (de)
TW (1) TW257677B (de)
WO (1) WO1993017036A1 (de)
ZA (1) ZA93746B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
DE4334823C2 (de) * 1993-10-09 1998-09-17 Schering Ag Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5998639A (en) * 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
AU703814B2 (en) * 1995-12-04 1999-04-01 Wyeth Antioxidant
DE19631543C1 (de) * 1996-07-25 1997-11-20 Schering Ag Verfahren zur Herstellung von 3-Sulfatoxy-estra-1,3,5(10)-trien-Derivaten I
DE19631542C1 (de) * 1996-07-25 1997-08-28 Schering Ag Verfahren zur Herstellung von 3-Sulfatoxy-estra-1,3,5(10)-trien-Derivaten II
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
ID18256A (id) * 1996-09-16 1998-03-19 American Home Prod Penggunaan dari 8,9-dehidro estron sebagai estrogen dengan hasil netral pada tingkat prolaktin
AR014096A1 (es) * 1996-10-11 2001-02-07 Wyeth Corp 17 alfa,8,9-deshidroestradiol y 17 beta delta 8,9 deshidroestradiol, el uso de los mismos para la manufactura de un medicamento, una composicionfarmaceutica que los comprende y un procedimiento para su preparacion.
ZA979204B (en) * 1996-10-16 1999-04-14 American Home Prod Use of 8,9-dehydroestrone in treating vasomotor symptoms
IL124213A (en) * 1997-05-02 2004-12-15 Akzo Nobel Nv Sulfation of estrogen mixtures
US6432643B1 (en) 1999-10-22 2002-08-13 Duke University Method of determining Alzheimer's disease risk using apolipoprotein E4 genotype analysis in combination with decreased estrogen levels
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20030158432A1 (en) * 2002-01-08 2003-08-21 Leonard Thomas W. Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
US8349819B2 (en) * 2002-10-09 2013-01-08 Dr. Reddy's Laboratories New York, Inc. Steroid extraction process from urine sources
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
WO2004091535A2 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
CA2566771A1 (en) * 2004-06-07 2005-12-22 Wyeth Sugar coatings and methods therefor
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
CA2601773A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
EP1898888A2 (de) * 2005-06-29 2008-03-19 Wyeth a Corporation of the State of Delaware Formulierungen von östrogenkonjugaten und bazedoxifen
EP2289487A1 (de) * 2005-12-27 2011-03-02 Teva Women's Health, Inc. Zubereitungen enthaltend konjugierte Östrogene, Applikatoren, Kits und Methoden zur Herstellung und Verwendung
BRPI0718558A2 (pt) * 2006-11-07 2013-11-19 Wyeth Corp Forma de dosagem sólida, composição aquosa, método para preparar uma forma de dosagem sólida, e, produto
TW200836773A (en) * 2007-01-12 2008-09-16 Wyeth Corp Tablet-in-tablet compositions
US20080194533A1 (en) * 2007-02-09 2008-08-14 Wyeth Process for selective sulfation of aromatic hydroxyl groups
US7902147B2 (en) * 2007-11-05 2011-03-08 Duke University Chronic lymphocytic leukemia prognosis and treatment
ES2436841T3 (es) 2009-10-27 2014-01-07 Wyeth Llc Formulaciones de bazedoxifeno con antioxidantes

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2834712A (en) * 1953-05-27 1958-05-13 American Home Prod Urinary estrogen compositions and methods for preparing them
US3079410A (en) * 1960-04-02 1963-02-26 Hoechst Ag Process for stabilizing anionic and cationic ester salts of 21-hydroxy-20-ketosteroids in an aqueous solution
US3959322A (en) * 1960-09-22 1976-05-25 Herchel Smith Synthesis of 13-alkyl-gon-4-ones
DE1200476B (de) * 1961-04-10 1965-09-09 Frosst & Co Charles E Stabilisierung von trockenen Zubereitungen synthetischer Alkalisalze von OEstronsulfat
US3551459A (en) * 1962-10-04 1970-12-29 Herchel Smith 13-methyl-8-isogonanes
US3394153A (en) * 1965-08-18 1968-07-23 Merck & Co Inc Process for the preparation of d, 1-8-dehydroestrone, and intermediates obtained therefrom
NL6805153A (de) * 1968-04-10 1969-10-14
US3644618A (en) * 1968-10-29 1972-02-22 Frosst & Co Charles E Stable composition of synthetic sodium estrone sulfate
US3608077A (en) * 1969-11-13 1971-09-21 Syntex Corp Stabilization of metal steroid alcohol sulfates
US3649621A (en) * 1969-12-19 1972-03-14 American Home Prod Novel 3-cyclopentyl ethers of 13-alkylgon-poly-enes
GB1451109A (en) * 1973-08-17 1976-09-29 Rech Et Dapplications Scient S Derivatives of oestrone and their use in therapy
GB1528321A (en) * 1975-07-07 1978-10-11 Leo Ab Acylation process for the preparation of phenolic n,n-di-substituted carbamate esters
SE439586B (sv) * 1975-09-05 1985-06-24 Kanebo Ltd Sett att framstella ett stabilt farmaceutiskt torrpreparat av ett alkalimetallsalt av dehydroepiandrosteronsulfat
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters

Also Published As

Publication number Publication date
SG49715A1 (en) 1998-06-15
ATE174342T1 (de) 1998-12-15
FI943903A0 (fi) 1994-08-25
DE69322497D1 (de) 1999-01-21
GR3029620T3 (en) 1999-06-30
CA2089707A1 (en) 1993-08-27
DK0628052T3 (da) 1999-07-12
AU711571B2 (en) 1999-10-14
LV12240A (lv) 1999-03-20
KR950700318A (ko) 1995-01-16
AR042262A2 (es) 2005-06-15
ES2125975T3 (es) 1999-03-16
JPH07504197A (ja) 1995-05-11
US6169082B1 (en) 2001-01-02
HK1020282A1 (en) 2000-04-07
MX9300969A (es) 1993-09-01
FI115915B (fi) 2005-08-15
EP0864583A2 (de) 1998-09-16
AU2007697A (en) 1997-07-03
JP3715645B2 (ja) 2005-11-09
DE69334073T2 (de) 2007-02-01
AU3726093A (en) 1993-09-13
US5210081A (en) 1993-05-11
FI943903A (fi) 1994-08-25
ZA93746B (en) 1994-08-03
HUT67553A (en) 1995-04-28
WO1993017036A1 (en) 1993-09-02
HU211971A9 (en) 1996-01-29
KR100256861B1 (ko) 2000-08-01
ES2274555T3 (es) 2007-05-16
DE69322497T2 (de) 1999-05-06
TW257677B (de) 1995-09-21
AR042345A2 (es) 2005-06-15
DK0864583T3 (da) 2006-12-04
HU9402457D0 (en) 1994-10-28
EP0864583B1 (de) 2006-10-11
PT864583E (pt) 2007-01-31
ATE342272T1 (de) 2006-11-15
EP0628052A1 (de) 1994-12-14
EP0864583A3 (de) 2004-07-21
HK1011369A1 (en) 1999-07-09
US5288717A (en) 1994-02-22
EP0628052B1 (de) 1998-12-09
DE69334073D1 (de) 2006-11-23
AU677181B2 (en) 1997-04-17

Similar Documents

Publication Publication Date Title
LV12240B (en) ESSENTIALS OF SURFACE METALS 8.9-DEHYDRESTRONES
DE2015573C3 (de) a-Aminomethyl-3-(hydroxy-, acyloxy- oder acyloxymethyl)-4-acyloxybenzylalkohole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE4141746A1 (de) 20-methyl-substituierte vitamin d-derivate
Banks et al. Biomolecules bearing the S-or SeAsMe2 function: amino acid and steroid derivatives
SK194892A3 (en) Method of production of diacetylreine
CH629768A5 (de) Verfahren zur herstellung von 5,6-cis- und 5,6-trans-10,19-dihydrovitamin d-derivaten.
DE3838779A1 (de) 14(alpha),17(alpha)-ethano-estratriene
US20030232797A1 (en) Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders
DE19943708B4 (de) Neue C13-substituierte Estra-1,3,5(10)-trien-3-yl-sulfamate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
PL174912B1 (pl) Nowe związki farmakologicznie czynne z grupy witamin D i sposób ich otrzymywania
EP0094951B1 (de) Neue prostacycline und verfahren zu ihrer herstellung
EP0131285B1 (de) Enamin-Derivate von Daunorubicin und Adriamycin und diese enthaltende pharmazeutische Zusammensetzungen
JP3108474B2 (ja) 活性型ビタミンｄ誘導体
DE1958383C3 (de) Leupeptine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US3142672A (en) Derivatives of nu-alpha-phenyl-and nu-alpha-biphenylylbutyric acids and amino sugars
DE2050072C3 (de) Aluminium-tri-3-acetyl-18 betaglycyrrthetinat, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen
JPH0725771B2 (ja) ２−アミノエタンスルホン酸亜鉛錯化合物
WO1988010252A1 (en) Prostaglandin derivates, their process and pharmaceutical compositions
DE2732144A1 (de) Salicylsaeurederivate
FR2563107A1 (fr) Medicaments a base de nouveaux derives du bornane
GB1595942A (en) 6-chloro-6-deoxy-mannose
DE2819211A1 (de) Benzylpyrimidine und verfahren zu deren herstellung
CH498089A (de) Verfahren zum Herstellen von neuen SH- oder SS-Glutathionsalzen
JPH0692392B2 (ja) 新規プソイドウリジン誘導体
DE1445017A1 (de) Neue Pyrimidine